trending Market Intelligence /marketintelligence/en/news-insights/trending/Wa2F7BhsK8RXTsKMb9H53A2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

J&J to invest in a new research facility in California

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


J&J to invest in a new research facility in California

Johnson & Johnson said it will make a significant investment to expand the presence and capabilities of its unit Janssen Research & Development LLC in South San Francisco, Calif.

The investment aims to support the leasing and construction of a research and development facility in the global innovation center of South San Francisco.

Johnson & Johnson's Janssen BioPharma Inc. executed a lease within the Healthpeak Properties Inc.'s South San Francisco project.

The personnel at this new facility will focus on infectious and retinal diseases, along with data science research for discovery, product development and supply.

Johnson & Johnson expects that the facility will be fully operational in 2022 upon completion of construction.